We are live on ! Find out more
TFCP

Twin Focus Capital Partners Portfolio holdings

AUM $983M
1-Year Est. Return 37.07%
This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+37.07%
3 Year Est. Return
+92.46%
5 Year Est. Return
+88%
10 Year Est. Return
+241.11%
AUM
$193M
AUM Growth
+$10.7M
Cap. Flow
+$2.84M
Cap. Flow %
1.47%
Top 10 Hldgs %
52.75%
Holding
101
New
2
Increased
18
Reduced
25
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 8.61%
2 Healthcare 1.83%
3 Communication Services 0.88%
4 Real Estate 0.77%
5 Technology 0.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCRX icon
101
Pacira BioSciences
PCRX
$1.04B
-4,516
Closed -$215K

Similar funds

Twin Focus Capital Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Twin Focus Capital Partners held 101 positions worth $193M, up 5.8% from $183M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 3%. Twin Focus Capital Partners opened 2 new positions and exited 1, leaving the 101-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.3% a quarter earlier, followed by Healthcare and Communication Services.

  • Twin Focus Capital Partners's largest Q3 2017 buy was Vanguard FTSE Pacific ETF: 3,000 shares worth $205K.
  • Twin Focus Capital Partners added most to Vanguard S&P 500 ETF in Q3 2017, an estimated $501K increase.
  • Twin Focus Capital Partners's biggest Q3 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $1.59M.
  • Twin Focus Capital Partners fully exited Pacira BioSciences in Q3 2017, selling an estimated $215K.
  • Twin Focus Capital Partners's ten largest holdings make up 53% of its $193M portfolio in Q3 2017.
  • Twin Focus Capital Partners opened 2 new positions and closed 1 in Q3 2017.
  • Twin Focus Capital Partners's portfolio value rose 5.8% quarter-over-quarter to $193M.

Based on Twin Focus Capital Partners's 13F filing for Q3 2017, filed 13 Nov 2017.